Preventing autoimmunity after alemtuzumab in multiple sclerosis: regulatory T cells resist expansion

David P J Hunt

doi:10.1093/brain/awag308

CrossrefInfo card

Preventing autoimmunity after alemtuzumab in multiple sclerosis: regulatory T cells resist expansion

David P J Hunt

Brain · 2026-11-04 · 149 (11) · 3681-3682

DOI: 10.1093/brain/awag308 ↗

Abstract Bibliographic details

Abstract

This scientific commentary refers to ‘Low-dose IL-2 fails to expand Tregs after alemtuzumab: insight into impaired immune tolerance in multiple sclerosis’, by Georgieva et al. (https://doi.org/10.1093/brain/awag171).

Bibliographic details

Authors: David P J Hunt
Journal: Brain
Year of publication: 2026
Volume / Issue: 149 / 11
Pages: 3681-3682
Publisher: Oxford University Press (OUP)
DOI: 10.1093/brain/awag308
ISSN: 0006-8950; 1460-2156
Source: Crossref

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.